drugset / Trial / NCT00426179

Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen

NCT00426179

Phase 1/2 Completed 30 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the effects of Imatinib on allergic inflammation following repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen.

Timeline

Start
2006-12
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Imatinib Small molecule